Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Forte Biosciences, Inc. | Director | Stock Option (right to buy) | 50K | Aug 20, 2024 | Direct | ||
Dicerna Pharmaceuticals Inc | Director | Common Stock | 0 | $38.25 | Dec 28, 2021 | Direct | |
Dicerna Pharmaceuticals Inc | Director | Director Stock Option (Right to Buy) | 0 | Dec 28, 2021 | Direct | ||
Dicerna Pharmaceuticals Inc | Director | Restricted Stock Units | 0 | Dec 28, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FBRX | Forte Biosciences, Inc. | Aug 20, 2024 | 1 | $0 | 4 | Aug 22, 2024 | Director |
FBRX | Forte Biosciences, Inc. | Sep 19, 2023 | 1 | $0 | 4 | Sep 20, 2023 | Director |
FBRX | Forte Biosciences, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Director |
FBRX | Forte Biosciences, Inc. | May 12, 2022 | 1 | $0 | 4 | May 16, 2022 | Director |
FBRX | Forte Biosciences, Inc. | May 12, 2022 | 0 | $0 | 3 | May 16, 2022 | Director |
DRNA | Dicerna Pharmaceuticals Inc | Dec 28, 2021 | 5 | -$127K | 4 | Dec 29, 2021 | Director |
DRNA | Dicerna Pharmaceuticals Inc | Jun 3, 2021 | 4 | $0 | 4 | Jun 7, 2021 | Director |